In short. How firm lumps form, how they present and why they are difficult to treat. Why technique and preparation matter more here than which substance was chosen.
Key points
- The risk is driven by how the substance is prepared, how deep it is placed, how much goes into one area and how far apart the sessions are.
- Those are decisions made by the person injecting, in the room rather than on a label.
- That is why the question worth asking is not which product is used but how the material is handled for the area being treated.
Firm lumps are the risk that decides whether this substance is a reasonable choice for a particular area, and they are the reason an assessment should discuss technique before it discusses products. They are uncommon, they are more likely in some places than others, and they are difficult to treat once established. That combination is what makes prevention the whole of the decision.
How they form
The material is placed as particles suspended in a carrier, and the tissue responds to it by building collagen around each one. When the particles sit close together, when they are placed near the surface, or when too much is given to one area at once, the response can become a firm mass rather than an even layer. The same process that produces the desired change produces the lump; what differs is how evenly the material is distributed and how much covering tissue sits over it. Sessions crowded together rather than properly spaced add to the risk.
How they present
A nodule may be palpable before it is visible, which is why the review at three months examines the tissue as well as the appearance. Some are small and firm and settle or soften over time. Others grow, become painful, or become visible under thin skin, and those need assessment rather than patience. A delayed inflammatory response can appear weeks or months after treatment, sometimes long after, and it may need treatment in its own right. Small firmness in the first weeks is common and is not the same finding.
Why technique outweighs the product
The risk is driven by how the substance is prepared, how deep it is placed, how much goes into one area and how far apart the sessions are. Those are decisions made by the person injecting, in the room rather than on a label. That is why the question worth asking is not which product is used but how the material is handled for the area being treated.
Why they are difficult to treat
There is no dissolving agent for this substance, so a lump cannot be switched off. What can be done is limited: observation, massage in the specific way it is prescribed, injected treatment for an inflammatory component, and occasionally surgical removal. Each of those is a management pathway rather than a correction, and none of them guarantees a return to the previous contour.
What should prompt an assessment
- A firm area that is growing, is painful, or has become visible under the skin.
- Redness, warmth, swelling or tenderness over a treated area, or any fever.
- A lump appearing months after treatment, even if it is not painful.
None of this makes the treatment unreasonable. It makes the choice of who injects, and the questions asked before the first session, the part of the decision that carries the most weight. A patient who asks how the substance is prepared, how deep it will be placed and what the plan is if a firm area appears months later has done more for their own outcome than any comparison of products could.
Frequently asked questions
How common are nodules after this treatment?
They are uncommon, and the honest answer is that they are uncommon enough that many patients never see one and common enough that every clinic treating this substance should have a plan for them. Frequency is not the useful question. Placement and preparation are.
What does a nodule feel like, and when does it appear?
A firm area under the skin that may be palpable before it is visible, sometimes weeks after treatment and sometimes considerably later. Small firmness in the first weeks is common and often settles. A lump that is growing, painful or visible is a different finding and should be assessed.
Can massage get rid of a nodule?
Small firm areas are sometimes massaged as part of the plan, and it is done in a specific way rather than as general rubbing. It is not a treatment for an established nodule, and it should be directed by the clinician managing the case rather than attempted at home on your own initiative.
Risks & Limitations
- Irreversibility: there is no dissolving agent for this substance. A lump, an asymmetry or an over-correction is managed over time, with injected treatment, or occasionally by removal, and never switched off.
- Nodules and granulomas — firm lumps or an inflammatory reaction that can appear weeks or months after treatment and may need assessment and treatment rather than simply resolving.
- Unevenness or over-correction. This substance is placed in an area that cannot be dissolved, so over-treatment is harder to correct than under-treatment.
- Firmness under the skin in the first weeks, which is expected and usually settles, but does not always.
- Infection or inflammation at an injection site, which needs prompt assessment rather than waiting.
- Bruising, swelling, tenderness and occasional headache after treatment.
- The volume visible on the day is the carrier rather than the effect. The result develops over months and cannot be judged early, it is not permanent, and the area continues to age.
When to Seek Care
- A firm, growing or painful lump at or near an injection site, appearing weeks or months after treatment — this needs assessment even when it is not painful.
- Redness, warmth, swelling or pus at an injection site, or fever.
- Skin breakdown, blistering, or a dusky or mottled patch over a treated area — seek care immediately.
- Increasing pain, or pain out of proportion to the injection.
- Difficulty breathing, facial swelling or a widespread rash — possible severe reaction; seek emergency care immediately.
References & Further Reading
- American Academy of Dermatology (AAD) — injectable and skin safety information
- American Society of Plastic Surgeons (ASPS) — injectable treatment guidance
- U.S. Food and Drug Administration (FDA) — approved injectable products and safety communications
- National Medical Products Administration (NMPA, China) — approved product status
- Chongqing West District Hospital — Plastic Surgery & Aesthetics Medical Center
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.